BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38355748)

  • 21. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
    Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
    Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.
    Schuhn A; Tobar TW; Gahlawat AW; Hauke J; Baumann L; Okun JG; Nees J
    Arch Gynecol Obstet; 2022 Nov; 306(5):1623-1632. PubMed ID: 35284957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound diagnosis of endometrial cancer by subjective pattern recognition in women with postmenopausal bleeding: prospective inter-rater agreement and reliability study.
    Wong M; Thanatsis N; Amin T; Bean E; Madhvani K; Jurkovic D
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):471-477. PubMed ID: 32621381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Metabolic Fingerprints Characterize Systemic Lupus Erythematosus.
    Li S; Ding H; Qi Z; Yang J; Huang J; Huang L; Zhang M; Tang Y; Shen N; Qian K; Guo Q; Wan J
    Adv Sci (Weinh); 2024 Jan; 11(2):e2304610. PubMed ID: 37953381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of endometrial volume and flow parameters under 3D ultrasound acquisition in combination with serum CA125 in endometrial lesions.
    Liao YM; Li Y; Yu HX; Li YK; Du JH; Chen H
    Taiwan J Obstet Gynecol; 2021 May; 60(3):492-497. PubMed ID: 33966734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteiomic patterns for endometrial cancer using SELDI-TOF-MS.
    Zhu LR; Zhang WY; Yu L; Zheng YH; Hu J; Liao QP
    J Zhejiang Univ Sci B; 2008 Apr; 9(4):286-90. PubMed ID: 18381802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum proteomic features for detection of endometrial cancer.
    Zhu LR; Zhang WY; Yu L; Zheng YH; Zhang JZ; Liao QP
    Int J Gynecol Cancer; 2006; 16(3):1374-8. PubMed ID: 16803533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
    Besso MJ; Montivero L; Lacunza E; Argibay MC; Abba M; Furlong LI; Colas E; Gil-Moreno A; Reventos J; Bello R; Vazquez-Levin MH
    Oncol Rep; 2020 Sep; 44(3):873-886. PubMed ID: 32705231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.
    Yang J; Barkley JE; Bhattarai B; Firouzi K; Monk BJ; Coonrod DV; Zenhausern F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer.
    He SM; Xing F; Sui H; Wu Y; Wang Y; Wang D; Chen G; Kong Z; Zhou SF
    Med Sci Monit; 2011 Nov; 17(11):CR618-625. PubMed ID: 22037740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
    Chen J; Liu J; Cao D
    BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer.
    Celsi F; Monasta L; Arrigoni G; Battisti I; Licastro D; Aloisio M; Di Lorenzo G; Romano F; Ricci G; Ura B
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
    Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
    Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of transrectal ultrasound in assessing endometrium of postmenopausal women with axial uterus.
    Wong M; Amin T; Thanatsis N; Foo X; Jurkovic D
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):414-419. PubMed ID: 34919769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
    Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
    Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium.
    Longacre TA; Broaddus R; Chuang LT; Cohen MB; Jarboe EA; Mutter GL; Otis CN; Zaino RJ;
    Arch Pathol Lab Med; 2017 Nov; 141(11):1508-1512. PubMed ID: 28301227
    [No Abstract]   [Full Text] [Related]  

  • 39. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panel.
    Visser NCM; van der Wurff AAM; IntHout J; Reijnen C; Dabir PD; Soltani GG; Alcala LSM; Boll D; Bronkhorst CM; Bult P; Geomini PMAJ; van Hamont D; van Herk HADM; de Kievit IM; Ngo H; Pijlman BM; Snijders MPML; Vos MC; Nagtegaal ID; Massuger LFAG; Pijnenborg JMA; Bulten J
    Hum Pathol; 2021 Nov; 117():68-78. PubMed ID: 34418427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.